Lack of chemokine (C-C motif) ligand 3 leads to decreased survival and reduced immune response after bacterial meningitis.

Pneumococcal meningitis, caused by Streptococcus pneumoniae, is the most common type of bacterial meningitis. The clinical management of this disease has been challenged by the emergence of multidrug-resistant Streptococcus pneumoniae, requiring the urgent development of new therapeutic alternatives. Over the course of bacterial meningitis, pathogen invasion is accompanied by a massive recruitment of peripheral immune cells, especially neutrophil granulocytes, which are recruited under the coordination of several cytokines and chemokines. Here, we used chemokine (C-C motif) ligand 3 (Ccl3)-deficient mice to investigate the functional role of CCL3 in a mouse model of pneumococcal meningitis. Following intrathecal infection with Streptococcus pneumoniae Ccl3-deficient mice presented a significantly shorter survival and higher bacterial load than wildtype mice, paralleled by an ameliorated infiltration of neutrophil granulocytes into the CNS. Blood sample analysis revealed that infected Ccl3-deficient mice showed a significant decrease in erythrocytes, hemoglobin and hematocrit as well as in the number of banded neutrophils. Moreover, infected Ccl3-deficient mice showed an altered cytokine expression profile. Glial cell activation remained unchanged in both genotypes. In summary, this study demonstrates that CCL3 is beneficial in Streptococcus pneumoniae-induced meningitis. Pharmacological modulation of the CCL3 pathways might, therefore, represent a future therapeutic option to manage Streptococcus pneumoniae meningitis.

Efficiency of two commercial on-farm pasteurizers for inactivation of mastitis pathogens in milk intended for feeding of calves.

Two commercially available pasteurizers for on farm pasteurization of milk intended for feeding calves were tested for their efficiency to inactivate mastitis pathogens. Raw bulk tank milk of the experimental farm Schaedtbek of the Max Rubner-Institute was artificially contaminated with twelve different strains of mastitis pathogens (intended level 7-8 log10 colony forming units [cfu]/ml). The average contamination level was 7.6 log10 cfu/ml in trials with pasteurizer 1 (P1) and 7.3 log10 cfu/ml in trials with pasteurizer 2 (P2), with lowest counts for yeasts (5.1 log10 cfu/ml for P1 and P2). Average reduction rates of > 5.8 log10 cfu/ml for P1 (72 degrees C, 12 s) and > 6.2 log10 cfu/ml for P2 (64 degrees C, 35 min) revealed an appropriate efficiency of both pasteurizers for practical purposes. Pathogens surviving pasteurization (enterococci in trials with both pasteurizers and of Staphylococcus aureus and Escherichia coli with P1) demonstrate the limits of pasteurization as a function of raw milk quality and emphasize the necessity for appropriate handling of pasteurized milk to prevent excessive multiplication of microbial pathogens.